Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Senti Biosciences, Inc. SNTI |
T. Rowe Price Associates, Inc. | 355,402 8.100% |
355,402 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Confluent, Inc. CFLT |
T. Rowe Price Associates, Inc. | 10,538,252 6.900% |
3,483,079 (+49.37%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | SentinelOne, Inc. S |
T. Rowe Price Associates, Inc. | 25,317,055 11.800% |
3,709,473 (+17.17%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Payoneer Global Inc. PAYO |
T. Rowe Price Associates, Inc. | 1,133,009 0.300% |
-18,594,651 (-94.26%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | DICE Therapeutics, Inc. DICE |
T. Rowe Price Associates, Inc. | 3,219,960 6.800% |
3,219,960 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | CI&T Inc CINT |
T. Rowe Price Associates, Inc. | 1,471,732 9.400% |
1,471,732 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Braze, Inc. BRZE |
T. Rowe Price Associates, Inc. | 536,761 0.900% |
-234,828 (-30.43%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Orchestra BioMed Holdings, Inc. OBIO |
T. Rowe Price Associates, Inc. | 685,801 6.100% |
685,801 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
T. Rowe Price Associates, Inc. | 3,619,560 13.700% |
431,055 (+13.52%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Aurora Innovation, Inc. AUR |
T. Rowe Price Associates, Inc. | 168,992 0.000% |
-56,173,745 (-99.70%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
T. Rowe Price Associates, Inc. | 3,014,377 9.600% |
993,740 (+49.18%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Peloton Interactive, Inc. PTON |
T. Rowe Price Associates, Inc. | 48,455,871 15.500% |
-11,453 (-0.02%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | CrossFirst Bankshares, Inc. CFB |
T. Rowe Price Associates, Inc. | 7,799 0.000% |
-4,675,129 (-99.83%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Utz Brands, Inc. UTZ |
T. Rowe Price Associates, Inc. | 29,004 0.000% |
-7,361,335 (-99.61%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | I-Mab IMAB |
T. Rowe Price Associates, Inc. | 281 0.000% |
-7,348,491 (-100.00%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
T. Rowe Price Associates, Inc. | 4,472,202 6.700% |
1,478,699 (+49.40%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
T. Rowe Price Associates, Inc. | 822,601 2.100% |
822,601 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Clear Secure, Inc. YOU |
T. Rowe Price Associates, Inc. | 27,063 0.300% |
-4,100,786 (-99.34%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Blue Foundry Bancorp BLFY |
T. Rowe Price Associates, Inc. | 4,367 0.000% |
-2,325,843 (-99.81%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | MongoDB, Inc. MDB |
T. Rowe Price Associates, Inc. | 6,696,183 9.700% |
-465,014 (-6.49%) |
Filing History |